Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterized by excessive fibrotic tissue ...

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

In idiopathic pulmonary fibrosis, higher risk of mortality and lung transplant is linked to small decreases in FVC% predicted and DLCO% predicted.

The outcomes of patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Alongside the global adoption of antifibrotic therapies, there is currently relentless research for biomarkers and ...

Oral submucous fibrosis (OSF) is a serious disease that impairs mouth functionality, often leading to restricted opening and ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

With that in mind, Medscape Medical News asked leading primary care physicians for their advice and insight on navigating the ...

The following is a summary of “Diagnostic accuracy of multi-organ point-of-care ultrasound for pulmonary embolism in ...

Introduction Interstitial lung disease (ILD) patients may develop a progressive phenotype usually characterised by ...

At present, transient elastography and the serum marker FibroTest are the most intensively evaluated non-invasive methods for the assessment of liver fibrosis ... and an ultrasound-based ...

Apr. 28, 2025 — Researchers have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and ...